NHS

News

NICE reverses stance on Celgene’s Revlimid for myeloma maint...

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.

Views & Analysis

Unlocking health data to improve oncology outcomes

As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment.

News

UK is first European country to see COVID-19 deaths pass 100...

More than 100,000 people have died within 28 days of a positive COVID-19 test in the UK, the first European country to meet that grim milestone.

News

Novi Sad, Serbia - October 6, 2014: Woman's hands Googling on electronic device.Woman hands holding and touching on Apple iPad mini with Google search web page on a screen.

Nearly half of UK young people buy meds after consulting “Dr...

It’s evident that relying on Google for a health diagnosis isn’t a good idea, but it seems a majority of UK people still do – and even buy medicines based on what they find.

News

NICE backs broad use for Gilead/Galapagos arthritis pill Jys...

Patients with rheumatoid arthritis (RA) in England will be able to get treatment with Gilead Sciences and Galapagos’ JAK inhibitor Jyseleca, after it was backed by cost-effectiveness agency

Digital